Canadian medical cannabis companyAurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, announced on Monday the launch of the newly developed Luo CBD lozenge. What HappenedThe product was developed by Vectura Fertin Pharma, and represents the company’s first medical cannabis CBD lozenge to be introduced in Canada. The move follows the announced commercial collaboration between Vectura Fertin Pharma’s subsidiary Cogent International and the Edmonton, Alberta-based company to leverage Aurora’s Canadian medical cannabis patient platfo…